RELATIONAL PARENTING THERAPY FOR OPIOID ABUSING MOTHERS

描述：（申请人摘要） 拟议的研究将涉及一项随机临床试验， 关系型育儿母亲小组（RPMG），一项旨在 有14岁以下子女的阿片类药物滥用妇女， 作为I期研究（P50-DA 09241）的一部分进行手动和中试。 这 干预措施是在认识到大量的心理社会 滥用药物的母亲及其子女面临的风险， 值得注意的是，目前缺乏对成瘾者的父母干预措施。 孩子过了婴儿期的母亲。 基于发展 从心理病理学的角度来看，这种综合治疗 解决多层次的逆境（个人，社区和家庭） 吸毒母亲面临的风险： 母亲的养育行为和心理社会困扰， 同时，他们的后代也会出现精神障碍。 RPMG是一个 结构化治疗，需要每周24次，每次1 1/2小时的小组会议 每个. 在第一阶段研究中收集的初步数据证明了这一承诺 RPMG在不同的父母行为和精神结果方面的差异 在母亲和她们的孩子中，在拟议的研究中，我们 寻求进行随机临床试验，比较RPMG 恢复训练（RT;一种类似于标准药物的手动治疗 咨询）。 RPMG和RT干预都将作为补充提供 接受美沙酮诊所定期提供的治疗。 八十 美沙酮维持的母亲将随机接受两种治疗 条件下，总样本量为160。 多种方法， 将获得多名知情人的评估，以衡量显著成果， 包括来自母亲及其子女的报告，以及来自母亲的 临床医生和孩子们的老师。 本研究将探讨以下具体目标：（1）到 评价RPMG与RT在以下方面的比较有效性： （a）方面的改进母亲的养育行为和态度， 精神障碍;以及（B.）在他们孩子的 日常社交能力;（2）评价 RPMG治疗收益的持久性，以及潜在的延迟治疗 通过对母亲和儿童进行6个月的随访评估， 在RPMG治疗的活跃期之后;和（3.）为研究如何 具体的母亲特征与治疗成功有关。 指导 在以前的研究中，这些特征将包括（a.）智力（B） 感觉寻求（c.）种族;及（d.）准备治疗。

DESCRIPTION: (Applicant's Abstract) The proposed study will involve a randomized clinical trial of the Relational Parenting Mothers' Group, (RPMG), an intervention designed for opioid abusing women with children less than 14 years of age, which was manualized and pilot tested as part of a Phase I study (P50-DA09241). This intervention was developed in recognition of the substantial psychosocial risks faced by substance abusing mothers and their offspring, and the notable lack of parenting interventions currently available for addicted mothers with children past the infancy years. Based on developmental psychopathology perspectives on resilience, this integrative treatment addresses multiple levels of adversity (individual, community, and family) faced by drug abusing mothers: risks that typically result in negative parenting behaviors and psychosocial distress among the mothers and concomitantly, psychiatric disturbance among their offspring. RPMG is a structured treatment, entailing 24 weekly group sessions of 1 1/2 hours each. Preliminary data collected in the Phase I study have attested to the promise of RPMG in terms of diverse parenting behaviors and psychiatric outcomes among both the mothers and their children, and in the proposed study, we seek to conduct a randomized clinical trial in which RPMG will be compared with Recovery Training (RT; a manualized treatment resembling standard drug counseling). Both RPMG and RT interventions will be offered as supplements to treatment regularly offered at the methadone clinics. Eighty methadon-maintained mothers will be randomized to each of the two treatment conditions, yielding a total sample size of 160. Multiple-method, multiple-informant assessments will be obtained to measure salient outcomes, including reports from the mothers and their children, and from the mothers' clinicians and the children's teachers. The following specific goals will be addressed within this study: (1.) To evaluate the comparative effectiveness of RPMG versus RT in terms of improvements in (a.) mothers' parenting behaviors and attitudes, and their psychiatric disturbance; as well as and (b.) in their children's levels of symptomatology and everyday social competence; (2.) To evaluate the durability of RPMG treatment gains, as well as potentially delayed treatment effects, via follow-up assessments of both mothers and children six months after the active phase of RPMG treatment; and (3.) To examine ways in which specific maternal characteristics relate to treatment success. Guided by previous research, these characteristics will include (a.) intelligence (b.) sensation seeking (c.) ethnicity; and (d.) readiness for treatment.